The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 16, Pages 3923
Publisher
MDPI AG
Online
2021-08-04
DOI
10.3390/cancers13163923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Profiling for Supernatants and Matched Cell Pellets of Pleural Effusions in Non–Small-Cell Lung Cancer
- (2020) Chan Xiang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
- (2020) Harry J. de Koning et al. NEW ENGLAND JOURNAL OF MEDICINE
- Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors
- (2020) Abbye E. McEwen et al. Frontiers in Cell and Developmental Biology
- Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
- (2020) Hiu Ting Chan et al. Molecular Oncology
- Integrating genomic features for non-invasive early lung cancer detection
- (2020) Jacob J. Chabon et al. NATURE
- Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation
- (2020) Min-Sun Cho et al. PLoS One
- Possible role of circulating tumor cells in early detection of lung cancer
- (2020) Cristina Poggiana et al. Journal of Thoracic Disease
- Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
- (2020) Charles-Hugo Marquette et al. Lancet Respiratory Medicine
- The Diagnostic Accuracy of Liquid Biopsy in EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis of 40 Studies
- (2020) Naiqun Wang et al. SLAS Technology
- Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review
- (2020) Rossella Bruno et al. Diagnostics
- Biomarkers for lung cancer screening and detection
- (2020) Edwin J. Ostrin et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients
- (2020) Francesco Cortiula et al. Diagnostics
- Consistency of genotyping data from simultaneously collected plasma circulating tumor DNA and tumor-DNA in lung cancer patients
- (2020) Jiali Zhang et al. Journal of Thoracic Disease
- Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
- (2020) Riziero Esposito Abate et al. Cancers
- Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel
- (2019) Jian Zhou et al. Microsystems & Nanoengineering
- Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
- (2019) Zhihua Guo et al. Thoracic Cancer
- Isolation of circulating tumor cells and detection of EGFR mutations in patients with non‑small‑cell lung cancer
- (2019) Qi Zhang et al. Oncology Letters
- Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC
- (2019) Mei-Mei Zheng et al. Journal of Thoracic Oncology
- Clinical Validation of a Cell-Free DNA Gene Panel
- (2019) Ju Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
- (2019) Yang Li et al. Cancer Medicine
- Whole Exome Sequencing of Cell-Free DNA for Early Lung Cancer: A Pilot Study to Differentiate Benign From Malignant CT-Detected Pulmonary Lesions
- (2019) Tina D. Tailor et al. Frontiers in Oncology
- Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
- (2019) B Lee et al. ANNALS OF ONCOLOGY
- Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor‐Mutant Lung Cancer
- (2019) Florian J. Fintelmann et al. ONCOLOGIST
- The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment
- (2019) Tengteng Wei et al. PLoS One
- Prognostic significance of molecular characteristics of cerebrospinal fluid for non‐small cell lung cancer patients with leptomeningeal metastasis
- (2019) Ning Li et al. Thoracic Cancer
- Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
- (2019) Melanie Janning et al. Cancers
- Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey
- (2019) Jeffrey P. Gregg et al. Translational Lung Cancer Research
- Liquid biopsy for rectal cancer: A systematic review
- (2019) Daniela Massihnia et al. CANCER TREATMENT REVIEWS
- EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
- (2019) C.R. Lindsay et al. EUROPEAN JOURNAL OF CANCER
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
- (2019) Kathryn C. Arbour et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer
- (2019) Yariswamy Manjunath et al. LUNG CANCER
- Prospective detection of mutations in cerebrospinal fluid, pleural effusion and ascites of advanced cancer patients to guide treatment decisions
- (2019) Sergio Villatoro et al. Molecular Oncology
- Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma
- (2019) Yuwei Liao et al. Cancer Medicine
- Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology
- (2019) Soo‐Ryum Yang et al. CANCER CYTOPATHOLOGY
- Release of circulating tumor cells during surgery for non-small cell lung cancer: are they what they appear to be?
- (2019) Menno Tamminga et al. CLINICAL CANCER RESEARCH
- An Integrated Microfluidic Chip and Its Clinical Application for Circulating Tumor Cell Isolation and Single‐Cell Analysis
- (2019) Mingxin Xu et al. CYTOMETRY PART A
- Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
- (2019) Francesca Chemi et al. NATURE MEDICINE
- Impact of EGFR mutation and ALK rearrangement on the outcomes of non–small cell lung cancer patients with brain metastasis
- (2019) Suresh K Balasubramanian et al. NEURO-ONCOLOGY
- Management of Brain Metastases in Non–Small-Cell Lung Cancer
- (2019) Vinicius Ernani et al. Journal of Oncology Practice
- Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis
- (2019) Yue Zhao et al. BMC Neurology
- Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline
- (2019) Bryan J. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
- (2019) Eirini Papadopoulou et al. PLoS One
- Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
- (2019) Lucie Benešová et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratory
- (2018) Sergey Nikolaev et al. ANALYTICAL BIOCHEMISTRY
- Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
- (2018) Y S Li et al. ANNALS OF ONCOLOGY
- False positive plasma genotyping due to clonal hematopoiesis
- (2018) Yuebi Hu et al. CLINICAL CANCER RESEARCH
- Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non–Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice
- (2018) Kentaro Ito et al. Clinical Lung Cancer
- Circulating tumor cells count as a predictor of survival in lung cancer
- (2018) Konstantinos Syrigos et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer
- (2018) Dana Wai Yi Tsui et al. EMBO Molecular Medicine
- Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience
- (2018) Paula Loveland et al. INTERNAL MEDICINE JOURNAL
- Towards a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multi-center study (CTCTrap)
- (2018) Kiki C. Andree et al. INTERNATIONAL JOURNAL OF CANCER
- Radiologic Pseudoprogression during Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer
- (2018) Sharyn I. Katz et al. Journal of Thoracic Oncology
- IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC)
- (2018) Christian Rolfo et al. Journal of Thoracic Oncology
- Leptomeningeal metastases in non-small-cell lung cancer
- (2018) Haiying Cheng et al. LANCET ONCOLOGY
- Effective assessment of low times MET amplification in pleural effusion after epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) acquired resistance
- (2018) Chang-guo Wang et al. MEDICINE
- Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling
- (2018) Vincent Plagnol et al. PLoS One
- Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens
- (2018) Liping Liu et al. Journal of Thoracic Disease
- Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer
- (2018) Masaki Hashimoto et al. Journal of Thoracic Disease
- Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
- (2018) Chia-Chi Lin et al. Lancet Respiratory Medicine
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies
- (2018) Fausto Petrelli et al. PLoS One
- Biological background of the genomic variations of cf-DNA in healthy individuals
- (2018) J Liu et al. ANNALS OF ONCOLOGY
- Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases
- (2018) Shenpeng Ying et al. CANCER BIOLOGY & THERAPY
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- Application of Cell-free DNA Analysis to Cancer Treatment
- (2018) Ryan B. Corcoran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of acquired resistance to afatinib clarified with liquid biopsy
- (2018) Tomomi Nakamura et al. PLoS One
- Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib
- (2018) Maximilian J. Hochmair et al. Targeted Oncology
- Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
- (2018) Markus Mayrhofer et al. Genome Medicine
- Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer
- (2018) Clement Brun et al. Journal of Thoracic Disease
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
- (2018) Young Kwang Chae et al. Journal of Thoracic Oncology
- Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer
- (2018) Alexa B. Schrock et al. Journal of Thoracic Oncology
- Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
- (2017) Julie Vendrell et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages
- (2017) Meng Yang et al. Journal of Hematology & Oncology
- Comparison of plasma to tissue DNA mutations in surgical patients with non–small cell lung cancer
- (2017) Kezhong Chen et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens
- (2017) Judith N. Müller et al. Journal of Thoracic Oncology
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Patients
- (2017) Baohong Yang et al. ONCOLOGY RESEARCH
- Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2
- (2017) Desiree Schenk et al. PLoS One
- An integrated risk predictor for pulmonary nodules
- (2017) Paul Kearney et al. PLoS One
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Clonal hematopoiesis
- (2017) Max Jan et al. SEMINARS IN HEMATOLOGY
- Perioperative detection of circulating tumour cells in patients with lung cancer
- (2017) Dimple Chudasama et al. Oncology Letters
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- Circulating tumor cells in early stage lung adenocarcinoma: a case series report and literature review
- (2017) Xu-Rui Jin et al. Oncotarget
- The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor
- (2017) Yating Chen et al. Cancer Management and Research
- Estimating Survival in Patients With Lung Cancer and Brain Metastases
- (2017) Paul W. Sperduto et al. JAMA Oncology
- Liquid Biopsies for Cancer: Coming to a Patient near You
- (2017) Nithya Krishnamurthy et al. Journal of Clinical Medicine
- A benchmark study on error-correction by read-pairing and tag-clustering in amplicon-based deep sequencing
- (2016) Tian-Hao Zhang et al. BMC GENOMICS
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer
- (2016) Anil Vachani et al. CHEST
- Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes
- (2016) Qing Kang et al. CLINICAL BIOCHEMISTRY
- Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
- (2016) P. Ballard et al. CLINICAL CANCER RESEARCH
- Complication rates of CT-guided transthoracic lung biopsy: meta-analysis
- (2016) W. J. Heerink et al. EUROPEAN RADIOLOGY
- Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy
- (2016) Keiran S.M. Smalley et al. INTERNATIONAL JOURNAL OF CANCER
- Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer
- (2016) Geoffrey R. Oxnard et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC
- (2016) Phil A.J. Crosbie et al. Journal of Thoracic Oncology
- ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study
- (2016) Martin Reck et al. Journal of Thoracic Oncology
- Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
- (2016) Fabrice Barlesi et al. LANCET
- Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer
- (2016) Fumio Imamura et al. LUNG CANCER
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection
- (2016) Clara Bayarri-Lara et al. PLoS One
- Circulating tumor DNA detection in lung cancer patients before and after surgery
- (2016) Nannan Guo et al. Scientific Reports
- High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer
- (2015) E. Pailler et al. ANNALS OF ONCOLOGY
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
- (2015) D. P. Steensma et al. BLOOD
- Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA
- (2015) J. Uchida et al. CLINICAL CHEMISTRY
- EGFR mutations in lung cancer: from tissue testing to liquid biopsy
- (2015) Francesca Fenizia et al. Future Oncology
- Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing
- (2015) Eric Samorodnitsky et al. HUMAN MUTATION
- Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
- (2015) Weijing Cai et al. JOURNAL OF CLINICAL ONCOLOGY
- Challenges in circulating tumor cell detection by the CellSearch system
- (2015) Kiki C. Andree et al. Molecular Oncology
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group
- (2015) Manfred Dietel et al. THORAX
- Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
- (2015) Stefano Sestini et al. Oncotarget
- Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays
- (2014) Britta Weber et al. BMC CANCER
- Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer
- (2014) Angela Alama et al. DRUG DISCOVERY TODAY
- An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer
- (2014) Maxim B. Freidin et al. LUNG CANCER
- Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: A prospective multicenter study in a real-world setting (GFPC study 12-01)
- (2014) Christos Chouaid et al. LUNG CANCER
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- “Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
- (2014) Marius Ilie et al. PLoS One
- Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
- (2014) J. Zhang et al. SCIENCE
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer
- (2014) Masaki Hashimoto et al. Interactive Cardiovascular and Thoracic Surgery
- Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer
- (2013) Emma Pailler et al. JOURNAL OF CLINICAL ONCOLOGY
- Size-selective collection of circulating tumor cells using Vortex technology
- (2013) Elodie Sollier et al. LAB ON A CHIP
- Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
- (2013) T. Iuchi et al. LUNG CANCER
- Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing
- (2013) Chang Dong Yeo et al. LUNG CANCER
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Implementing personalized cancer genomics in clinical trials
- (2013) Richard Simon et al. NATURE REVIEWS DRUG DISCOVERY
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR
- (2013) Jiatao Lou et al. PLoS One
- Meta-analysis of Circulating Tumor Cells as a Prognostic Marker in Lung Cancer
- (2012) Xue-Lei Ma et al. Asian Pacific Journal of Cancer Prevention
- Genetic heterogeneity and cancer drug resistance
- (2012) Nicholas C Turner et al. LANCET ONCOLOGY
- Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage IIV Non-Small Cell Lung Cancer Patients
- (2012) Xiao Zhao et al. RESPIRATION
- EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
- (2012) Caroline J. Chapman et al. TUMOR BIOLOGY
- Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications☆☆☆
- (2011) Soichiro Funaki et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidental Findings in Imaging Research
- (2010) Nicholas M. Orme et al. ARCHIVES OF INTERNAL MEDICINE
- Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
- (2010) V. Hofman et al. CLINICAL CANCER RESEARCH
- Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey
- (2010) Daniel Morgensztern et al. Journal of Thoracic Oncology
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations
- (2008) Chikako Suzuki et al. RADIOGRAPHICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search